Grant: Discovery Grants Program - Individual
Queen's University
$34,000.00
Modification of DNA Repair Activities by the Nutraceutical Sulforaphane
EF 2014-15
Résumé
Background Nutraceuticals are chemicals present in the diet that have physiological benefits or provide protection against chronic disease. One such compound, sulforaphane, is found in cruciferous plants such as broccoli and Brussels sprouts. We have recently made the novel finding that treatment of mice with sulforaphane increases the ability of their liver cells to repair damage to DNA by a specific repair pathway called nucleotide excision repair (NER). The ability of cells to protect themselves against DNA damage is essential for prevention of chronic disease. Consequently, repair processes exist to counteract the ongoing damage that occurs to DNA. Two critical DNA repair processes are NER and base excision repair (BER). NER removes DNA lesions caused by binding of bulky reactive chemicals, and BER repairs DNA damage caused by oxidative stress. In earlier studies, we found that certain mutagenic compounds not only damage DNA, but under certain conditions, upregulate repair. Because of the critical importance of DNA repair in maintaining the integrity of the genome, there could be considerable benefit to agents that upregulate DNA repair without also being DNA-damaging. The previously unrecognized ability of sulforaphane to augment DNA repair may be an important factor in the ability of nutraceuticals like sulforaphane to provide protection against toxic chemical insult. However, we do not yet know how sulforaphane enhances NER or how widespread the effect is throughout the body. We propose to: optimize the sulforaphane dosing protocol for maximal NER augmentation; determine whether BER is also enhanced by suforaphane; determine the molecular mechanism by which sulforaphane augments DNA repair; and determine if sulforaphane-mediated increases in DNA repair occur in organs other than the liver. Rationale and Plan To assess the effects of sulforaphane on DNA repair, we will first treat mice with different doses of sulforaphane. At several timepoints thereafter, we will remove livers, lungs, kidneys, and brains from the mice. To measure DNA repair activity in the organs, we will use assays we have established, in which mouse tissue extracts are used as the sources of repair proteins, and plasmids containing specific types of DNA damage are used as repair substrates. For NER, we will use DNA damaged by the fungal toxin aflatoxin B1 (a food contaminant) as well as DNA damaged by the tobacco nitrosamine NNK. For BER, the DNA substrate will have damage caused by attack of the hydroxyl radical, which is an important mediator of oxidative stress. The mechanism(s) by which sulforaphane augments DNA repair activity is/are likely to involve alterations in specific DNA repair proteins. We will measure the levels and activities of the key NER and BER proteins. To reveal the mechanisms of DNA repair protein alterations, we will focus on two major candidate processes for sulforaphane's activity: acting as an activator of the nuclear factor-like 2 (Nrf2) signalling system; and inhibiting the activity of histone deacetylase enzymes. Both of these processes regulate gene expression. To assess their importance, we will use a combination of molecular biological methods, chemical tools known to affect the signalling systems, and a genetic model of mice deficient in Nrf2. Training of HQP Trainees will work with experimental animals in vivo and will use molecular biological techniques to learn fundamental mechanisms of action of a common nutraceutical. The skill sets learned will be applicable to many other areas of biological research. These studies will be done in the context of a project that has the potential to be of benefit to many Canadians, and could provide a new direction for nutraceutical development.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2014-03914
Name nom
Massey, Thomas
Department département
Biomedical & Molecular Sciences
Organization id
29
Institution établissement
Queen's University
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2014
Competition year année de concours
2014
Award amount
34000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1502
Committee name en
Biological Systems and Functions
Committee name fr
Systèmes et fonctions biologiques
Area of application code
505
Area of application group en
Manufacturing processes and products
Area of application group fr
Procédés et produits industriels
Area of application en
Veterinary pharmaceuticals
Area of application fr
Produits pharmaceutiques à usage vétérinaire
Research subject code
6101
Research subject group en
Food science and technology
Research subject group fr
Science et technologie de l'alimentation
Research subject en
Food chemistry and analysis
Research subject fr
Chimie alimentaire et analyse
Partie
1
Nb partie
5
Application title
Modification of DNA Repair Activities by the Nutraceutical Sulforaphane
Keyword
NSERC
Application summary
Background Nutraceuticals are chemicals present in the diet that have physiological benefits or provide protection against chronic disease. One such compound, sulforaphane, is found in cruciferous plants such as broccoli and Brussels sprouts. We have recently made the novel finding that treatment of mice with sulforaphane increases the ability of their liver cells to repair damage to DNA by a specific repair pathway called nucleotide excision repair (NER). The ability of cells to protect themselves against DNA damage is essential for prevention of chronic disease. Consequently, repair processes exist to counteract the ongoing damage that occurs to DNA. Two critical DNA repair processes are NER and base excision repair (BER). NER removes DNA lesions caused by binding of bulky reactive chemicals, and BER repairs DNA damage caused by oxidative stress. In earlier studies, we found that certain mutagenic compounds not only damage DNA, but under certain conditions, upregulate repair. Because of the critical importance of DNA repair in maintaining the integrity of the genome, there could be considerable benefit to agents that upregulate DNA repair without also being DNA-damaging. The previously unrecognized ability of sulforaphane to augment DNA repair may be an important factor in the ability of nutraceuticals like sulforaphane to provide protection against toxic chemical insult. However, we do not yet know how sulforaphane enhances NER or how widespread the effect is throughout the body. We propose to: optimize the sulforaphane dosing protocol for maximal NER augmentation; determine whether BER is also enhanced by suforaphane; determine the molecular mechanism by which sulforaphane augments DNA repair; and determine if sulforaphane-mediated increases in DNA repair occur in organs other than the liver. Rationale and Plan To assess the effects of sulforaphane on DNA repair, we will first treat mice with different doses of sulforaphane. At several timepoints thereafter, we will remove livers, lungs, kidneys, and brains from the mice. To measure DNA repair activity in the organs, we will use assays we have established, in which mouse tissue extracts are used as the sources of repair proteins, and plasmids containing specific types of DNA damage are used as repair substrates. For NER, we will use DNA damaged by the fungal toxin aflatoxin B1 (a food contaminant) as well as DNA damaged by the tobacco nitrosamine NNK. For BER, the DNA substrate will have damage caused by attack of the hydroxyl radical, which is an important mediator of oxidative stress. The mechanism(s) by which sulforaphane augments DNA repair activity is/are likely to involve alterations in specific DNA repair proteins. We will measure the levels and activities of the key NER and BER proteins. To reveal the mechanisms of DNA repair protein alterations, we will focus on two major candidate processes for sulforaphane's activity: acting as an activator of the nuclear factor-like 2 (Nrf2) signalling system; and inhibiting the activity of histone deacetylase enzymes. Both of these processes regulate gene expression. To assess their importance, we will use a combination of molecular biological methods, chemical tools known to affect the signalling systems, and a genetic model of mice deficient in Nrf2. Training of HQP Trainees will work with experimental animals in vivo and will use molecular biological techniques to learn fundamental mechanisms of action of a common nutraceutical. The skill sets learned will be applicable to many other areas of biological research. These studies will be done in the context of a project that has the potential to be of benefit to many Canadians, and could provide a new direction for nutraceutical development.